CELLULAR TECHNOLOGIES IN TREATMENT OF LUNG DISEASES – ARE WHETHER PROSPECTS?

Abstract


In the article the problem of treatment of lung pathology by cellular technologies is analyzed. Results of experiments, giving hopes for positive outcomes of clinical trials are summarized. Possible mechanisms of influence stem cells on regenerative processes in lungs are considered.

A V Averyanov

Email: averyanovav@mail.ru

A G Konoplyannikov

Email: konopl@obninsk.ru

  1. Joyce N., Annett G., Wirthlin L. et al. Mesenchymal stem cells for the treatment of neurodegenerative disease // Regen. Med. 2010. Vol. 5 (6). P. 933-946.
  2. Wen Y., Chen B., Ildstad S.T. Stem cell-based strategies for the treatment of type 1 diabetes mellitus // Expert Opin. Biol. Ther. 2011. Vol. 11 (1). P. 41-53.
  3. Hodgkinson C.P., Gomez J.A., Mirotsou M., Dzau V.J. Genetic engineering of mesenchymal stem cells and its application in human disease therapy // Hum. Gene Ther. 2010. Vol. 21 (11). P. 1513-1526.
  4. Sullivan S., Cowan C., Eggan K. (Eds.) Human embryonic stem cells. A John Wiley & Sons, Ltd., Chennai, 2007. 404 pp.
  5. Lakshmipathy U. et al. (Eds.) Emerging technology platforms for stem cells. A John Wiley & Sons, Inc., New Jersey, 2009, 506 pp.
  6. Battler A., Leor J. (Eds.) Stem cells and gene-based therapy. Frontiers in regenerative medicine. Springer, 2006. 422 pp.
  7. Zhen G., Liu H., Gu N., Zhang H. Mesenchymal stem cells transplantation protects against rat pulmonary emphysema // Front Biosci. 2008. Vol. 13. P. 3415-3422.
  8. Zhen G., Xue Z., Zhao J. et al. Mesenchymal stem cell transplantation increases expression of vascular endothelial growth factor in papain-induced emphysematous lungs and inhibits apoptosis of lung cells // Cytotherapy. 2010. Vol. 12 (5). P. 605-614.
  9. Schweitzer K., Johnstone B.H., Garrison J. et al. Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking // Am. J. Respir. Crit. Care Med. 2011. Vol. 183 (2). P. 215-225.
  10. Sala E., Villena C., Balaguer C. et al. Abnormal levels of circulating endothelial progenitor cells during exacerbations of COPD // Lung. 2010. Vol. 188 (4). P. 331-338.
  11. Palange P., Testa U., Huertas A. et al. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD // Eur. Respir. J. 2006. Vol. 27 (3). P. 529-541.
  12. Huertas A., Testa U., Riccioni R. Bone marrow-derived progenitors are greatly reduced in patients with severe COPD and low-BMI // Respir. Physiol. Neurobiol. 2010. Vol. 170 (1). P. 23-31.
  13. Ishizawa K., Kubo H., Yamada M. et al. Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema // FEBS Lett. 2004. Vol. 556 (1-3). P. 249-252.
  14. Kotton D.N., Ma B.Y., Cardoso W.V. et al. Bone marrow-derived cells as progenitors of lung alveolar epithelium // Development. 2001. Vol. 128 (24). P. 5181-5188.
  15. Spees J.L., Pociask D.A., Sullivan D.E. et al. Engraftment of bone marrow progenitor cells in a rat model of asbestos-induced pulmonary fibrosis // Am. J. Respir. Crit. Care Med. 2007. Vol. 176 (4). P. 385-394.
  16. Moodley Y., Ilancheran S., Samuel C. Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair // Am. J. Respir. Crit. Care Med. 2010. Vol. 182 (5). P. 643-651.
  17. Moodley Y., Atienza D., Manuelpillai U. et al. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury // Am. J. Pathol. 2009. Vol. 175 (1). P. 303-313.
  18. Курсова Л.В., Конопляников А.Г., Пасов В.В. и др. Возможности применения аутологичных мезенхимальных стволовых клеток в лечении лучевых повреждений легких // Клеточные технологии в биологии и медицине. 2009. Т. 6б № 2. С. 108-112.
  19. Rochefort G.Y., Delorme B., Lopez A. Multi-potential mesenchymal stem cells are mobilized into peripheral blood by hypoxia // Stem Cells. 2006. Vol. 24 (10). P. 2202-2208.
  20. Firth A.L., Yao W., Ogawa A. Multipotent mesenchymal progenitor cells are present in endarterectomized tissues from patients with chronic thromboembolic pulmonary hypertension // Am. J. Physiol. Cell Physiol. 2010. Vol. 298 (5). P. C1217-C1225.
  21. Umar S., de Visser Y.P., Steendijk P. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension // Am. J. Physiol. Heart Circ. Physiol. 2009. Vol. 297 (5). P. H1606-H1616.
  22. He Z.X., Wang H.W., Shang F. et al. Administrating bone marrow mesenchymal stem cells to treat the experimental pulmonary arterial hypertension in rats // Zhonghua Yi Xue Za Zhi. 2009. Vol. 89 (30). P. 2110- 2115.
  23. Kanki-Horimoto S., Horimoto H., Mieno S. et al. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension // Circulation. 2006. Vol. 114 (1 Suppl). P. I181-I185.
  24. Mao M., Wang S.N., Lv X.J. et al. Intravenous delivery of bone marrow-derived endothelial progenitor cells improves survival and attenuates lipopolysaccharide-induced lung injury in rats // Shock. 2010. Vol. 34 (2). P. 196-204.
  25. Lam C.F., Liu Y.C., Hsu J.K. Autologous transplantation of endothelial progenitor cells attenuates acute lung injury in rabbits // Anesthesiology. 2008. Vol. 108 (3). P. 392-401.
  26. Lee J.W., Fang X., Gupta N. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung // Proc. Natl. Acad. Sci. USA. 2009. Vol. 106 (38). P. 16357-16362.
  27. Xu J., Woods C.R., Mora A.L. et al. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice // Am. J. Physiol. Lung Cell Mol. Physiol. 2007. Vol. 293. P. L131-L141.
  28. Ерохин В.В., Цыб А.Ф., Чуканов В.И. и др. Клеточные технологии в терапии хронического мультирезистентного туберкулеза легких // Проблемы туберкулеза и болезней легких. 2006. № 8. С. 3-5.
  29. Васильева И.А., Коноплянников А.Г., Ерохин В.В. и др. Лечебный эффект системной трансплантации культивируемых аутогенных мезенхимальных стволовых клеток костного мозга у больных с резистентными формами туберкулеза легких // Клеточная трансплантология и тканевая инженерия. 2007. Т. 4 (1). С. 77-80.
  30. Maurya D.K., Doi C., Kawabata A. et al. Therapy with un-engineered naive rat umbilical cord matrix stem cells markedly inhibits growth of murine lung adenocarcinoma // BMC Cancer. 2010. Vol. 10. P. 590.
  31. Loebinger M.R., Kyrtatos P.G., Turmaine M. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles // Cancer Res. 2009. Vol. 69 (23). P. 8862-8867.
  32. Loebinger M.R., Eddaoudi A., Davies D., Janes S.M. Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer // Cancer Res. 2009. Vol.69 (10). P. 4134-4142.
  33. Grisendi G., Bussolari R., Cafarelli L. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy // Cancer Res. 2010. Vol. 70 (9). P. 3718-3729.
  34. Eramo A., Lotti F., Sette G. et al. Identification and expansion of the tumorigenic lung cancer stem cell population // Cell Death Differ. 2008. Vol. 15. P. 504-514.
  35. Mimeault M., Hauke R., Metha P.P., Batra S.K. Recent advances in cancer stem/progenitor cell research: therapeutic implications to overcome resistance to the most aggressive cancers // J. Cell Mol. Med. 2007. Vol. 11. P. 981-1011.
  36. Jeon E.S., Lee I.H., Heo S.C. Mesenchymal stem cells stimulate angiogenesis in a murine xenograft model of A549 human adenocarcinoma through an LPA1 receptor-dependent mechanism // Biochim. Biophys. Acta. 2010. Vol. 1801 (11). P. 1205-1213.
  37. Krause D.S., Theise N.D., Collector M.I. et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell // Cell. 2001. Vol. 105. P. 369-377.
  38. Kotton D.N., Ma B.Y., Cardoso W.V. et al. Bone marrow-derived cells as progenitors of lung alveolar epithelium // Development. 2001. Vol. 128. P. 5181-5188.
  39. Wang G., Bunnell B.A., Painter R.G. et al. Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis // Proc. Natl. Acad. Sci. USA. 2005. Vol. 102. P. 186-191.
  40. Kotton D.N., Fabian A.J., Mulligan R.C. Failure of bone marrow to reconstitute lung epithelium // Am. J. Respir. Cell Mol. Biol. 2005. Vol. 33. P. 328-334.
  41. Loi R., Beckett T., Goncz K.K. et al. Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells // Am. J. Respir. Crit. Care Med. 2006. Vol. 173. P. 171-179.
  42. Lee J.W., Gupta N., Serikov V. Potential applica- tion of mesenchymal stem cells in acute lung injury // Expert. Opin. Biol.Ther. 2009. Vol. 9 (10). P. 1259-1270.
  43. Rasmusson I., Le Blanc K., Sundberg B., Ringden O. Mesenchymal stem cells stimulate anti-body secretion in human B cells // Scand. J. Immunol. 2007. Vol. 65. P. 336-343.
  44. Raffaghello L., Bianchi G., Bertolotto M. et al. Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche // Stem Cells. 2008. Vol. 26 (1). P. 151-162.
  45. Roomans G.M. Tissue engineering and the use of stem/progenitor cells for airway epithelium // Eur. Cell Mater. 2010. Vol. 19. P. 284-299.
  46. www. ClinicalTrials.gov

Views

Abstract - 164

PlumX


Copyright (c) 2010 Averyanov A.V., Konoplyannikov A.G.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.